FrancophonIA/ELRC3.0 huggingface dataset:
English: Dosage adjustments in patients with haematological adverse reactions: Dosage adjustment of zidovudine may be necessary if the haemoglobin level falls below 9 g/dl or 5.59 mmol/l or the neutrophil count falls below 1.0 x 109/l (see sections 4.3 and 4.4).
Slovenian: Prilagajanje odmerka pri bolnikih z neželenimi hematološkimi reakcijami: Če se vrednost hemoglobina zmanjša pod 9 g/dl ali 5,59 mmol/l, ali se število nevtrofilcev zmanjša pod 1,0 x 109/l (glejte poglavji 4.3 in 4.4), bo verjetno potrebno odmerek zidovudina prilagoditi.
English: Autoimmune disorders (such as Graves' disease and autoimmune hepatitis) have also been reported to occur in the setting of immune reactivation; however, the reported time to onset is more variable and these events can occur many months after initiation of treatment.
Slovenian: Gravesove bolezni in avtoimunskega hepatitisa), toda opisani čas do začetka je bolj spremenljiv in ti dogodki se lahko pojavijo veliko mesecev po uvedbi zdravljenja.
English: Microcrystalline cellulose (E460), sodium starch glycollate, colloidal silicon dioxide, magnesium stearate
Slovenian: Jedro tablete: mikrokristalna celuloza (E460) natrijev karboksimetilškrob koloidni silicijev dioksid magnezijev stearat
English: This loss of body fat has been shown to be not fully reversible after discontinuation of zidovudine.
Slovenian: Izkazalo se je, da po prekinitvi zdravljenja z zidovudinom ta izguba telesnega maščevja ni v celoti ozdravljiva.
English: URICOSURIC Probenecid/Lamivudine
Slovenian: URIKOZURIKI probenecid/lamivudin
English: Children weighing from 14 kg to 21 kg: the recommended oral dose of Combivir is one-half tablet taken twice daily.
Slovenian: Otroci s telesno maso od 14 kg do 21 kg: Priporočeni peroralni odmerek zdravila Combivir je polovica tablete dvakrat na dan.
English: Zidovudine and stavudine maintain their antiretroviral activities against lamivudine-resistant HIV-1.
Slovenian: Zidovudin in stavudin ohranita protiretrovirusno aktivnost na virus HIV-1, ki je odporen na lamivudin.
English: NAME OF THE MEDICINAL PRODUCT Combivir 150 mg/300 mg film-coated tablets
Slovenian: IME ZDRAVILA Combivir 150 mg/300 mg filmsko obložene tablete
English: Read the information ‘Other possible side effects of combination therapy for HIV' in
Slovenian: Preberite dodatne informacije v poglavju 4 »Drugi možni neželeni učinki kombiniranega zdravljenja okužbe s HIV« v tem navodilu.
English: • vincristine, vinblastine or doxorubicin, to treat cancer.
Slovenian: vinkristinom, vinblastinom ali doksorubicinom).
English: Combivir was shown to be bioequivalent to lamivudine 150 mg and zidovudine 300 mg given as separate tablets, when administered to fasting subjects.
Slovenian: Rezultati so pokazali, da je zdravilo Combivir bioekvivalentno 150 mg odmerku lamivudina in 300 mg odmerku zidovudina danih v ločenih tabletah, če ju bolniki vzamejo na tešče.
English: In any case, initiation of susceptible NRTI's should always be preferred to maintenance of lamivudine therapy.
Slovenian: V vsakem primeru ima uvedba zdravljenja z NRTI, proti katerim virus ni odporen, prednost pred nadaljnjo uporabo lamivudina.
English: Rare : Oral mucosa pigmentation, taste perversion and dyspepsia.
Slovenian: Občasni: napenjanje Redki: pigmentacija ustne sluznice, motnje v okušanju in dispepsija.
English: ANTIHISTAMINES (HISTAMINE H1 RECEPTOR ANTAGONISTS) Ranitidine/Lamivudine
Slovenian: ANTIHISTAMINIKI (ANTAGONISTI HISTAMINSKIH RECEPTORJEV H1)
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING BLISTER PACK OUTER CARTON
Slovenian: PODATKI NA ZUNANJI OVOJNINI ŠKATLA S PRETISNIMI OMOTI
English: (often referred to as PCP)
Slovenian: Pneumocystis jiroveci (pogosto omenjena kot PCP);
English: Concomitant treatment, especially acute therapy, with potentially nephrotoxic or myelosuppressive medicinal products (e.g. systemic pentamidine, dapsone, pyrimethamine, co-trimoxazole, amphotericin, flucytosine, ganciclovir, interferon, vincristine, vinblastine and doxorubicin) may also increase the risk of adverse reactions to zidovudine.
Slovenian: Tveganje neželenih učinkov na zidovudin lahko poveča tudi sočasno zdravljenje, zlasti akutno zdravljenje, s potencialno mielosupresivnimi zdravili (npr. sistemskim pentamidinom, dapsonom, pirimetaminom, kotrimoksazolom, amfotericinom, flucitozinom, ganciklovirjem, interferonom,
English: Lamivudine and zidovudine have been widely used as components of antiretroviral combination therapy with other antiretroviral agents of the same class (NRTIs) or different classes (PIs, nonnucleoside reverse transcriptase inhibitors).
Slovenian: Lamivudin in zidovudin se veliko uporabljata v kombinirani protiretrovirusni terapiji z drugimi protiretrovirusnimi zdravili iste skupine (nukleozidni in nukleotidni zaviralci reverzne transkriptaze) ali v kombinaciji s protiretrovirusnimi zdravili iz drugih skupin (zaviralci proteaz, PI; nenukleozidni zaviralci reverzne transkriptaze).
English: • stavudine, to treat HIV infection
Slovenian: • stavudin za zdravljenje okužbe s HIV;
English: Multiple drug antiretroviral therapy containing lamivudine has been shown to be effective in antiretrovirally-naive patients as well as in patients presenting with viruses containing the M184V mutations.
Slovenian: ki še niso bili deležni protiretrovirusne terapije, kot tudi pri bolnikih okuženih z virusi, ki vsebujejo mutacije M184V.
English: Tell your doctor or pharmacist if any of the side effects get severe or troublesome, or if you notice any side effects not listed in this leaflet.
Slovenian: Obvestite vašega zdravnika ali farmacevta, če katerikoli neželeni učinek postane resen ali moteč,
English: INFORMATION IN BRAILLE combivir 17.
Slovenian: Shranjevanje zdravila Combivir 6.
English: As a general rule, when deciding to use antiretroviral agents for the treatment of HIV infection in pregnant women and consequently for reducing the risk of HIV vertical transmission to the newborn, the animal data as well as the clinical experience in pregnant women should be taken into account.
Slovenian: kadar se odločamo o uporabi antiretrovirusnih učinkovin za zdravljenje okužbe z virusom HIV pri nosečnicah in posledično za zmanjšanje tveganja vertikalnega prenosa na novorojenčka.
English: Opportunistic infections: Patients receiving Combivir or any other antiretroviral therapy may continue to develop opportunistic infections and other complications of HIV infection.
Slovenian: Oportunistične okužbe: Ker se pri bolnikih, ki se zdravijo z zdravilom Combivir ali s katerim koli drugim protiretrovirusnim zdravljenjem, še vedno lahko pojavijo oportunistične okužbe in drugi zapleti vezani na okužbo z virusom HIV, morajo bolniki ostati pod skrbnim kliničnim nadzorom zdravnikov z izkušnjami pri zdravljenju okužbe z virusom HIV.
English: ANTIRETROVIRAL MEDICINAL PRODUCTS Didanosine/Lamivudine
Slovenian: ANTIRETROVIRUSNA ZDRAVILA didanozin/lamivudin
English: MARKETING AUTHORISATION NUMBER(S) EU/1/98/058/001
Slovenian: ŠTEVILKA (ŠTEVILKE) DOVOLJENJA (DOVOLJENJ) ZA PROMET EU/1/98/058/001
English: There is limited experience of overdosage with Combivir.
Slovenian: 4.9 Preveliko odmerjanje Izkušnje s prevelikim odmerjanjem zdravila Combivir so omejene.
English: Metabolism and nutrition disorders Very Rare: Lactic acidosis
Slovenian: Presnovne in prehranske motnje Zelo redki: laktacidoza
English: The 5'-glucuronide of zidovudine is the major metabolite in both plasma and urine, accounting for approximately 50-80% of the administered dose eliminated by renal excretion.
Slovenian: Zidovudin 5'-glukuronid je glavni presnovek zidovudina v plazmi in v urinu, nanj odpade približno
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 150 mg lamivudine and 300 mg zidovudine.
Slovenian: Vsaka filmsko obložena tableta vsebuje 150 mg lamivudina in 300 mg zidovudina.
English: ANTI-INFECTIVE PRODUCTS Atovaquone/Lamivudine
Slovenian: ANTIINFEKTIVNA ZDRAVILA atovakon/lamivudin
English: • lactic acidosis (excess lactic acid in the blood; see the next section, ‘Other possible side effects of combination therapy for HIV')
Slovenian: • težave z jetri, kot so zlatenica, povečana ali zamaščena jetra, vnetje jeter (hepatitis), • laktacidoza (čezmerno kopičenje mlečne kisline v krvi; glejte poglavje »Drugi možni neželeni učinki kombiniranega zdravljenja okužbe s HIV«), • vnetje trebušne slinavke (pankreatitis),
English: ViiV Healthcare S.r.l Tel: + 39 (0)45 9212611
Slovenian: Tel: + 39 (0)45 9212611
English: A bioequivalence study compared Combivir with lamivudine 150 mg and zidovudine 300 mg tablets taken together.
Slovenian: Zdravilo Combivir so v raziskavi bioekvivalentnosti primerjali s 150 mg tabletami lamivudina in 300 mg tabletami zidovudina, ki so jih bolniki jemali skupaj.
English: MARKETING AUTHORISATION NUMBER(S) EU/1/98/058/002
Slovenian: ŠTEVILKA(E) DOVOLJENJA (DOVOLJENJ) ZA PROMET EU/1/98/058/002
English: General disorders and administration site conditions Common : Malaise
Slovenian: Splošne težave in spremembe na mestu aplikacije Pogosti: splošno slabo počutje
English: 6.6 Special precautions for disposal
Slovenian: 6.6 Posebni varnostni ukrepi za odstranjevanje Ni posebnih navodil za odstranjevanje.
English: You need to know about important signs and symptoms to look out for while you are taking Combivir.
Slovenian: Medtem ko jemljete zdravilo Combivir, morate biti seznanjeni s pomembnimi znaki in simptomi, na katere morate biti pozorni.
English: Metabolism of lamivudine is a minor route of elimination.
Slovenian: Biotransformacija: Presnova lamivudina le v manjši meri prispeva k njegovemu izločanju.
English: As dosage adjustment of Combivir is not possible, separate preparations of zidovudine and lamivudine should be used.
Slovenian: Combivir prilagajanje odmerka posamezne učinkovine ni možno, je potrebno uporabiti zidovudin in lamivudin kot samostojni zdravili.
English: When you are being treated for HIV, it can be hard to tell whether a symptom is a side effect of Combivir or other medicines you are taking, or an effect of the HIV disease itself.
Slovenian: Med zdravljenjem okužbe s HIV, je včasih težko reči ali je simptom neželeni učinek zdravila
English: NAME OF THE MEDICINAL PRODUCT Combivir 150 mg/300 mg tablets Lamivudine/zidovudine
Slovenian: IME ZDRAVILA Combivir 150 mg/300 mg tablete lamivudin/zidovudin
English: Some medicines interact with Combivir
Slovenian: Nekatera zdravila medsebojno delujejo z zdravilom Combivir To so:
English: Combivir 150 mg/300 mg film-coated tablets lamivudine/zidovudine
Slovenian: Combivir 150 mg/300 mg filmsko obložene tablete lamivudin/zidovudin
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each film-coated tablet contains lamivudine 150 mg zidovudine 300 mg
Slovenian: Vsaka filmsko obložena tableta vsebuje lamivudin 150 mg zidovudin 300 mg
English: Some people taking Combivir or other combination treatments for HIV are more at risk of serious side effects.
Slovenian: Bodite posebno pozorni pri jemanju zdravila Combivir Nekateri bolniki, ki jemljejo zdravilo Combivir ali druga kombinirana zdravila za zdravljenje okužbe s HIV, so bolj ogroženi zaradi resnih neželenih učinkov.
English: OPIOIDS Methadone/Lamivudine
Slovenian: OPIOIDI metadon/lamivudin
English: Blood and lymphatic system disorders Common : Anaemia, neutropenia and leucopenia Uncommon: Thrombocyopenia and pancytopenia (with marrow hypoplasia) Rare : Pure red cell aplasia
Slovenian: Pogosti: anemija, nevtropenija in levkopenija Občasni: trombocitopenija in pancitopenija (s hipoplazijo kostnega mozga)
English: Tel: + 34 902 051 260 es-ci@viivhealthcare.com
Slovenian: Tel: + 351 21 094 08 01 viiv.fi.pt@viivhealthcare.com
English: ANTIFUNGALS Fluconazole/Lamivudine
Slovenian: ANTIMIKOTIKI flukonazol/lamivudin
English: Treatment with Combivir should be stopped immediately if clinical signs, symptoms or laboratory abnormalities suggestive of pancreatitis occur.
Slovenian: Če klinični znaki, simptomi ali laboratorijska odstopanja kažejo na možnost pankreatitisa, je potrebno zdravljenje z zdravilom Combivir nemudoma prekiniti.
English: Therefore the concomitant use of lamivudine with cladribine is not recommended
Slovenian: Zato sočasna uporaba lamivudina in kladribina ni priporočljiva (glejte poglavje
English: No Combivir dosage adjustment necessary, unless patient has renal impairment (See Section 4.2).
Slovenian: razen če ima bolnik okvaro ledvic (glejte poglavje 4.2).
English: Cartons containing opaque polyvinyl chloride/foil blister packs.
Slovenian: Škatle vsebujejo neprozorne (polivinilklorid/folija) pretisne omote.
English: Clarithromycin/Lamivudine Interaction not studied.
Slovenian: AUC fenitoina ↑↓ valprojska kislina/lamivudin Študij medsebojnega delovanja zdravil ni.
English: Signs of osteonecrosis include:
Slovenian: Znaki osteonekroze so: • togost sklepov,
English: Probenecid/Zidovudine (500 mg four times daily/2mg/kg thrice daily)
Slovenian: probenecid/zidovudin (500 mg štirikrat na dan/2 mg/kg trikrat na dan)
English: Combivir contains lamivudine and zidovudine, therefore any interactions identified for these individually are relevant to Combivir.
Slovenian: 4.5 Medsebojno delovanje z drugimi zdravili in druge oblike interakcij Zdravilo Combivir vsebuje lamivudin in zidovudin, zato je katerakoli interakcija, povezana s posamezno zdravilno učinkovino, pomembna tudi za zdravilo Combivir.
English: − If you get any of the side effects talk to your doctor or pharmacist.
Slovenian: - Če opazite katerikoli neželeni učinek, se posvetujte z zdravnikom ali farmacevtom.
English: Rare : Insomnia, paraesthesiae, somnolence, loss of mental acuity, convulsions
Slovenian: Pogosti: omotičnost Redki: nespečnost, parestezija, dremavost, zmanjšana sposobnost koncentracije, krči
English: clinically.
Slovenian: HIV.
English: Immune Reactivation Syndrome: In HIV-infected patients with severe immune deficiency at the time of institution of combination antiretroviral therapy (CART), an inflammatory reaction to asymptomatic or residual opportunistic pathogens may arise and cause serious clinical conditions, or aggravation of symptoms.
Slovenian: nastane vnetna reakcija na asimptomatične ali rezidualne oportunistične patogene in povzroči resna klinična stanja ali poslabšanje simptomov.
English: Renal and urinary disorders Rare: Urinary frequency
Slovenian: Redki: pogosto uriniranje
English: • high doses of co-trimoxazole, an antibiotic
Slovenian: • visoki odmerki antibiotika kotrimoksazola;
English: What Combivir is and what it is used for What you need to know before you take Combivir How to take Combivir
Slovenian: Kaj morate vedeti, preden boste vzeli zdravilo Combivir Ne uporabljajte zdravila Combivir:
English: How to store Combivir
Slovenian: Shranjevanje zdravila Combivir
English: No antagonistic effects in vitro were seen with zidovudine and other antiretrovirals (tested agents: abacavir, didanosine and interferon-alpha).
Slovenian: Antagonističnih učinkov z zidovudinom in drugimi protiretrovirusnimi učinkovinami (preskušane učinkovine: abakavir,
English: • feeling sick (nausea), being sick (vomiting)
Slovenian: • slabost (navzea), bruhanje,
English: Very rare : Aplastic anaemia
Slovenian: Redki: čista aplazija rdečih krvnih celic Zelo redki: aplastična anemija
English: Single dose lamivudine oral solution 300 mg
Slovenian: Enkraten odmerek lamivudina 300 mg peroralne raztopine lamivudin:
English: Skin and subcutaneous tissue disorders Uncommon : Rash and pruritus Rare : Nail and skin pigmentation, urticaria and sweating
Slovenian: Pogosti: pigmentacija nohtov in kože, urtikarija in znojenje Bolezni mišično-skeletnega sistema in vezivnega tkiva Pogosto: mialgija
English: Common side effects These may affect up to 1 in 10 people:
Slovenian: Pojavijo se pri do 1 od 10 bolnikov:
English: Not applicable
Slovenian: Peroralna uporaba
English: OTHER
Slovenian: SERIJE
English: Scored tablets
Slovenian: Bolezni prebavil
English: Common : Vomiting, abdominal pain and diarrhoea Uncommon : Flatulence
Slovenian: Pogosti: bruhanje, bolečine v trebuhu in diareja
English: Zidovudine:
Slovenian: Zidovudin:
English: ANTIMYCOBACTERIALS Rifampicin/Lamivudine
Slovenian: rifampicin/lamivudin
English: Do not store above 30oC.
Slovenian: Zdravilo Combivir shranjujte pri temperaturi do 30 ºC.
English: Some people taking Combivir develop a condition called lactic acidosis, together with an enlarged liver.
Slovenian: Laktacidoza je redek, vendar resen neželeni učinek Pri nekaterih ljudeh, ki jemljejo zdravilo Combivir, se lahko razvije stanje, ki se imenuje laktacidoza,
English: Cardiac disorders Rare :Cardiomyopathy
Slovenian: Redko: kardiomiopatija Bolezni dihal, prsnega koša in mediastinalnega prostora
English: EU/1/15/1020/001 Raxone
Slovenian: EU/1/15/1020/001
English: MA (EU) number (Invented) name
Slovenian: Št. dovoljenja za promet (EU)
English: Oral use bottle (HDPE)
Slovenian: 150 mg Filmsko obložena tableta peroralna uporaba plastenka (HDPE)
English: The standard dose is one tablet once a day.
Slovenian: Standardni odmerek je ena tableta enkrat dnevno.
English: Dopamine is important for controlling movement and coordination.
Slovenian: Dopamin je pomemben za nadzor gibanja in koordinacije.
English: The full EPAR for Rasagiline Mylan can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Slovenian: Celotno evropsko javno poročilo o oceni zdravila (EPAR) za zdravilo Razagilin Mylan je na voljo na spletni strani agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: This is a summary of the European public assessment report (EPAR) for Rasagiline Mylan.
Slovenian: To je povzetek evropskega javnega poročila o oceni zdravila (EPAR) za zdravilo Razagilin Mylan.
English: Rasagiline Mylan EMA/281859/2016
Slovenian: Razagilin Mylan EMA/75811/2016
English: They are linked to a reduction in the effect of levodopa, when the patient experiences sudden switches between being ‘on' and able to move, and being ‘off' and having difficulty moving about.
Slovenian: Povezana so z zmanjšanim učinkom levodope, ko bolnik doživlja nenadne preskoke med stanjem, ko se lahko giba, in stanjem, ko ima z gibanjem težave.
English: Rasagiline Mylan is available as tablets (1 mg).
Slovenian: Zdravilo Razagilin Mylan je na voljo v tabletah (1 mg).
English: The Committee recommended that Rasagiline Mylan be approved for use in the EU.
Slovenian: Priporočil je, da se zdravilo Razagilin Mylan odobri za uporabo v EU.
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) concluded that, in accordance with EU requirements, Rasagiline Mylan has been shown to have comparable quality and to be bioequivalent to Azilect.
Slovenian: Odbor za zdravila za uporabo v humani medicini (CHMP) pri agenciji je zaključil, da je bilo v skladu z zahtevami EU dokazano, da ima zdravilo Rasagaline Mylan primerljivo raven kakovosti kot zdravilo Azilect ter da mu je biološko enakovredno.
English: What measures are being taken to ensure the safe and effective use of Rasagiline Mylan?
Slovenian: Kateri ukrepi se izvajajo za zagotovitev varne in učinkovite uporabe zdravila Razagilin Mylan?
English: This means that Rasagiline Mylan is similar to a ‘reference medicine' already authorised in the European Union (EU) called Azilect.
Slovenian: To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Azilect.
English: Because Rasagiline Mylan is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine's.
Slovenian: Ker je zdravilo Razagilin Mylan generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so njegove koristi in tveganja enaki kot pri referenčnem zdravilu.
English: A risk management plan has been developed to ensure that Rasagiline Mylan is used as safely as possible.
Slovenian: Za zagotovitev čim varnejše uporabe zdravila Razagilin Mylan je bil pripravljen načrt obvladovanja tveganj.
English: What are the benefits and risks of Rasagiline Mylan?
Slovenian: Kakšne so koristi in tveganja, povezani z zdravilom Razagilin Mylan?
English: By increasing levels of dopamine in the parts of the brain that control movement and coordination, Rasagiline Mylan reduces the symptoms of Parkinson's disease, such as stiffness and slowness of movement.
Slovenian: S povečevanjem ravni dopamina v delih možganov, ki nadzorujejo gibe in koordinacijo, zdravilo Razagilin Mylan lajša simptome Parkinsonove bolezni, kot sta okornost in počasnost gibov.
English: For more information about treatment with Rasagiline Mylan, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Slovenian: Za več informacij o zdravljenju z zdravilom Razagilin Mylan preberite navodilo za uporabo (ki je prav tako del EPAR) ali se posvetujte z zdravnikom ali farmacevtom.
English: Rasagiline Mylan can be used either alone, or as an add-on to levodopa (another medicine used in Parkinson's disease) in patients who are having fluctuations in the control of their condition.
Slovenian: Zdravilo Razagilin Mylan se lahko uporablja samostojno ali kot dodatek levodopi (drugemu zdravilu, ki se uporablja pri Parkinsonovi bolezni) pri bolnikih z nihanji pri nadzoru njihovega stanja.
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Rasagiline Mylan, including the appropriate precautions to be followed by healthcare professionals and patients.
Slovenian: V skladu s tem načrtom so bile v povzetek glavnih značilnosti zdravila Razagilin Mylan in navodilo za njegovo uporabo vključene informacije o varnosti, vključno s previdnostnimi ukrepi, ki jih morajo upoštevati zdravstveni delavci in bolniki.
English: Therefore, the CHMP's view was that, as for Azilect, the benefit outweighs the identified risk.
Slovenian: Zato je menil, da njegove koristi enako kot pri zdravilu Azilect odtehtajo znana tveganja.
English: Because Rasagiline Mylan is a generic medicine, studies in people have been limited to tests to determine that it is bioequivalent to the reference medicine, Azilect.
Slovenian: Ker je zdravilo Razagilin Mylan generično zdravilo, so bile študije pri ljudeh omejene na preskuse za ugotavljanje, ali je biološko enakovredno referenčnemu zdravilu Azilect.
English: For practical information about using Rasagiline Mylan, patients should read the package leaflet or contact their doctor or pharmacist.
Slovenian: Za praktične informacije o uporabi zdravila Razagilin Mylan naj bolniki preberejo navodilo za uporabo ali se posvetujejo z zdravnikom ali farmacevtom.
English: Rasagiline Mylan is a medicine used to treat adults with Parkinson's disease (a progressive brain disorder that causes shaking, slow movement and muscle stiffness).
Slovenian: Zdravilo Razagilin Mylan se uporablja za zdravljenje Parkinsonove bolezni (napredujoče okvare možganov, ki povzroča tresavico, upočasnjeno gibanje in okorelost mišic) pri odraslih.
English: Rasagiline Mylan rasagiline
Slovenian: Razagilin Mylan razagilin
English: Other information about Rasagiline Mylan
Slovenian: Druge informacije o zdravilu Razagilin Mylan
English: Rasagiline Mylan is a ‘generic medicine'.
Slovenian: Zdravilo Razagilin Mylan je „generično zdravilo“.
English: What is Rasagiline Mylan and what is it used for?
Slovenian: Kaj je zdravilo Razagilin Mylan in za kaj se uporablja?
English: It is not intended to provide practical advice on how to use Rasagiline Mylan.
Slovenian: Povzetek ni namenjen zagotavljanju praktičnih nasvetov o njegovi uporabi.
English: Why is Rasagiline Mylan approved?
Slovenian: Zakaj je bilo zdravilo Razagilin Mylan odobreno?
English: Rasagiline Mylan contains the active substance rasagiline.
Slovenian: Zdravilo Razagilin Mylan vsebuje zdravilno učinkovino razagilin.
English: It blocks the enzyme monoamine oxidase type B, which breaks down a substance called dopamine in the brain.
Slovenian: Zdravilna učinkovina v zdravilu Razagilin Mylan je razagilin, zaviralec monoaminooksidaze tipa B. Razagilin blokira encim monoaminooksidaze tipa B, ki v možganih razgrajuje snov, imenovano dopamin.
English: How has Rasagiline Mylan been studied?
Slovenian: Kako je bilo zdravilo Razagilin Mylan raziskano?